Sugar Maple Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History
Sugar Maple Asset Management, LLC
- $115 Million
- Q2 2025
A detailed history of Sugar Maple Asset Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Sugar Maple Asset Management, LLC holds 14,300 shares of HALO stock, worth $986,414. This represents 0.65% of its overall portfolio holdings.
Number of Shares
14,300
Previous 10,300
38.83%
Holding current value
$986,414
Previous $657,000
13.09%
% of portfolio
0.65%
Previous 0.56%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
605Shares Held
127MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.22 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$845 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$409 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$239 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$234 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.61B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...